Watch Episode 6
Short on time? Watch the 30-second version.
What the interviewer is really testing
- Judgement. Can you tell a real release-blocker from a cosmetic defect?
- Courage. Will you raise your hand when the pressure to release is high?
- Communication. Can you explain the risk so that business leaders understand it, and act on it?
The weak answer vs the strong answer
Here's the weak answer: "QA never stops a release. We just report defects."
It sounds humble, but it tells the interviewer you see QA as a defect counter, not a quality leader. When a serious issue reaches production, "I logged it" is not an answer.
The 3 red lines and how to say no
First, the three red lines. I raise a no-go when I see any of these.
- Open critical or high defects in core business flows. In healthcare, that's anything touching claims payment, eligibility or member data.
- Exit criteria not met. High-risk areas untested, regression not complete, or performance not verified.
- Compliance, security or data-integrity issues. In healthcare, a HIPAA exposure or wrong payments to members are never acceptable risks.
Now, how to say no. Present the risk objectively, with data: what fails, who is affected, how many, and how badly. Give options: fix and re-test, release without the affected feature, or release with monitoring and a rollback plan.
Then the business decides, and the decision is documented, with the residual risk written down and signed off.
“QA doesn't own the go-live decision. QA owns making the risk visible.”
A real example
Here's a real example. I'll keep the client anonymous.
During UAT on a US healthcare program, we found that a business rule had been misinterpreted. In production, it would have affected thousands of members.
We recommended holding that feature. We presented the impact with data, ran a root-cause analysis, fixed the rule, ran targeted regression, and re-ran UAT with the business.
The business agreed, and signed off on the fix.
The result: zero customer impact.
After that, we added business-rule reviews with subject-matter experts earlier, and traced every test case to a business rule.
Follow-up questions to expect
What if they release anyway?
That's the business's right. I document the decision and the residual risk, then prepare monitoring, a support plan and a rollback, so we're ready if it fails.
Have you ever been wrong?
Be honest. Say what you learned, for example to quantify the risk better, so you raise fewer false alarms.
All 40 questions, answered: the Interview Kit
Delivery, Project, Program and QA Manager questions, 10 of each, with the weak answer, the strong answer, the line to say and the follow-ups. A 24-page PDF for ₹999, or $15 outside India.